Form D · Other
Body Labs Inc
New York, NY · CIK 0001603763
Offering snapshot reported Sep 10, 2015 · SEC filing
- Reported sold
- $4.1M Offering amount: $4.1M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 26, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 10, 2015 | Initial | $4,099,292 | No comparison | 11 | SEC filing |
| Mar 27, 2014 | Initial | $2,190,431 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-247384
Offering of Series A Preferred shares. Amounts reported include value of notes and interest converted into Series A Preferred shares.
Source: Form D, filed Sep 10, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael J. Black | Director |
| Joseph Ferrara | Director |
| Lawrence Lenihan | Director |
| William J. O'farrell | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
7 West 18 Th Street Fifth Floor
New York, NY, 10011
New York, NY, 10011